STOCK TITAN

Kraig Biocraft Laboratories Reports Record-Setting Recombinant Spider Silk Production in 2024

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Positive)
Tags

Kraig Biocraft Laboratories (OTCQB: KBLB) has achieved a significant production milestone, manufacturing over 1,200 pounds of recombinant spider silk cocoon in the past 12 months. This output exceeds the combined production of all previous years, marking a major breakthrough in commercialization efforts.

The record-setting production was achieved through the company's newest hybrid spider silk production strain, which modified traditional silkworms to produce spider silk-based fibers. This advancement demonstrates Kraig Labs' success in scaling up from laboratory innovation to sustainable commercial production, positioning the company to address global demand for performance fibers across various consumer markets.

Kraig Biocraft Laboratories (OTCQB: KBLB) ha raggiunto un importante traguardo di produzione, realizzando oltre 1.200 libbre di bozzolo di seta di ragno ricombinante negli ultimi 12 mesi. Questa quantità supera la produzione combinata di tutti gli anni precedenti, segnando una grande svolta negli sforzi di commercializzazione.

La produzione da record è stata ottenuta attraverso il nuovo ceppo ibrido di produzione di seta di ragno della compagnia, che ha modificato i tradizionali bachi da seta per produrre fibre a base di seta di ragno. Questo progresso dimostra il successo di Kraig Labs nel passare dall'innovazione di laboratorio alla produzione commerciale sostenibile, posizionando l'azienda per rispondere alla domanda globale di fibre performanti in vari mercati di consumo.

Kraig Biocraft Laboratories (OTCQB: KBLB) ha alcanzado un hito de producción significativo, fabricando más de 1,200 libras de capullo de seda de araña recombinante en los últimos 12 meses. Esta producción supera la producción combinada de todos los años anteriores, marcando un importante avance en los esfuerzos de comercialización.

La producción récord se logró a través de la nueva cepa híbrida de producción de seda de araña de la empresa, que modificó los gusanos de seda tradicionales para producir fibras basadas en seda de araña. Este avance demuestra el éxito de Kraig Labs en escalar desde la innovación de laboratorio hasta la producción comercial sostenible, posicionando a la empresa para abordar la demanda global de fibras de rendimiento en varios mercados de consumo.

크레이그 생명공학 연구소 (OTCQB: KBLB)는 지난 12개월 동안 1,200파운드 이상의 재조합 거미줄 누에고치를 생산함으로써 중요한 생산 이정표를 달성했습니다. 이 생산량은 이전 모든 해의 총합을 초과하며, 상업화 노력에 있어 큰 돌파구를 의미합니다.

기록적인 생산은 회사의 최신 하이브리드 거미줄 생산 균주를 통해 이루어졌으며, 이는 전통적인 누에를 수정하여 거미줄 기반 섬유를 생산하게 했습니다. 이 발전은 크레이그 연구소가 실험실 혁신에서 지속 가능한 상업 생산으로 확장하는 데 성공했음을 보여주며, 다양한 소비자 시장에서 성능 섬유에 대한 글로벌 수요를 충족할 수 있는 위치를 갖추게 합니다.

Kraig Biocraft Laboratories (OTCQB: KBLB) a atteint un jalon de production significatif, fabriquant plus de 1 200 livres de cocon de soie de araignée recombinante au cours des 12 derniers mois. Ce volume dépasse la production combinée de toutes les années précédentes, marquant une avancée majeure dans les efforts de commercialisation.

La production record a été réalisée grâce à la nouvelle souche hybride de production de soie d'araignée de l'entreprise, qui a modifié les vers à soie traditionnels pour produire des fibres à base de soie d'araignée. Cette avancée démontre le succès de Kraig Labs dans le passage de l'innovation en laboratoire à la production commerciale durable, positionnant l'entreprise pour répondre à la demande mondiale de fibres de performance sur divers marchés de consommation.

Kraig Biocraft Laboratories (OTCQB: KBLB) hat einen bedeutenden Produktionsmeilenstein erreicht und in den letzten 12 Monaten über 1.200 Pfund rekombinante Spinnenseidekokons produziert. Diese Menge übersteigt die gesamte Produktion aller vorherigen Jahre und markiert einen großen Durchbruch in den Kommerzialisierungsbemühungen.

Die rekordverdächtige Produktion wurde durch den neuesten hybriden Spinnenseidenproduktionstamm des Unternehmens erreicht, der traditionelle Seidenraupen modifiziert hat, um spinnenseidenbasierte Fasern zu produzieren. Dieser Fortschritt zeigt den Erfolg von Kraig Labs, von Laborinnovationen zur nachhaltigen kommerziellen Produktion überzugehen, und positioniert das Unternehmen, um der globalen Nachfrage nach leistungsfähigen Fasern auf verschiedenen Verbrauchermärkten gerecht zu werden.

Positive
  • Record production of 1,200 pounds of spider silk cocoon in 12 months
  • Production volume exceeds all previous years combined
  • Successful implementation of new hybrid spider silk production strain
  • Demonstrated ability to scale from lab to commercial production
Negative
  • None.

Milestone Surpasses All Previous Years Combined Production, Signifying Major Breakthrough in Commercialization Efforts

ANN ARBOR, Mich., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), the leading developer of spider silk-based fibers, reports that it has produced more than 1,200 pounds of recombinant spider silk cocoon over the last 12 months. This milestone represents more than the combined production of all prior years, underscoring the Company's significant advancements in scaling up spider silk production for commercial applications.

The successful production surge was driven by Kraig Labs' newest hybrid spider silk production strain, which transformed traditional silkworms into producers of spider silk-based fibers. This record output demonstrates the Company's ability to bridge the gap between laboratory innovation and scalable, sustainable production.

"We are proud to share this exciting production milestone. This achievement is a clear indicator of the tremendous progress our team has made in optimizing spider silk production," said Kim Thompson, Founder and CEO of Kraig Labs. "This achievement puts us on track to begin addressing the global demand for performance fibers across a range of consumer end markets."

Kraig Labs' focus on building a reliable and scalable production model has positioned the Company as a leader in recombinant spider silk manufacturing. This accomplishment sets the stage for expanded production capacity and accelerated commercialization of its eco-friendly and high-performance silk fibers.

For more details about this breakthrough and other advancements the Company has made this year please see the Company's investor conference at www.kraiglabs.com/videos or through the Company's YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com


FAQ

How many pounds of spider silk cocoon did KBLB produce in 2024?

Kraig Biocraft Laboratories produced over 1,200 pounds of recombinant spider silk cocoon in 2024.

What technology breakthrough enabled KBLB's record spider silk production?

KBLB's newest hybrid spider silk production strain, which transformed traditional silkworms into producers of spider silk-based fibers, enabled the record production.

How does KBLB's 2024 spider silk production compare to previous years?

The 2024 production of over 1,200 pounds exceeds the combined production of all previous years in the company's history.

What markets is KBLB targeting with its spider silk production?

KBLB is targeting global markets for performance fibers across various consumer end markets.

KRAIG BIOCRAFT LABS INC

OTC:KBLB

KBLB Rankings

KBLB Latest News

KBLB Stock Data

114.22M
776.63M
25.21%
Specialty Chemicals
Basic Materials
Link
United States of America
Ann Arbor